WallStreetZenWallStreetZen

NASDAQ: CGEM
Cullinan Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CGEM past revenue growth

How has CGEM's revenue growth performed historically?
Company
N/A
Industry
148.4%
Market
16.96%
CGEM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CGEM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CGEM earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$153.2M
Current Profit Margin
0%

CGEM Return on Equity

Current Company
-32.1%
Current Industry
-63.5%
Current Market
188%
CGEM's Return on Equity (-32.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CGEM announces earnings.

CGEM Return on Assets

Current Company
-30.4%
Current Industry
2.9%
CGEM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CGEM Return on Capital Employed

Current Company
-36.68%
Current Industry
19.5%
CGEM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CGEM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CGEM$0.00-$166.97M-$153.16M-100.00%N/A
ALXO$0.00-$158.40M-$160.81M-100.00%N/A
VRDN$314.00k-$235.32M-$237.73M-48.16%N/A
EYPT$46.02M-$69.00M-$70.80M+58.70%N/A
ETNB$0.00-$133.26M-$142.19MN/AN/A
View Top Biotech Stocks

CGEM earnings dates

Next earnings date
May 9, 2024

Cullinan Therapeutics Earnings & Revenue FAQ

What were CGEM's earnings last quarter?

On Invalid Date, Cullinan Therapeutics (NASDAQ: CGEM) reported Q4 2023 earnings per share (EPS) of -$0.54, up 11.48% year over year. Total Cullinan Therapeutics earnings for the quarter were -$23.80 million. In the same quarter last year, Cullinan Therapeutics's earnings per share (EPS) was -$0.61.

If you're new to stock investing, here's how to buy Cullinan Therapeutics stock.

What was CGEM's earnings growth in the past year?

As of Q2 2024, Cullinan Therapeutics's earnings has grown year over year. Cullinan Therapeutics's earnings in the past year totalled -$153.16 million.

What is CGEM's earnings date?

Cullinan Therapeutics's earnings date is Invalid Date. Add CGEM to your watchlist to be reminded of CGEM's next earnings announcement.

What was CGEM's revenue last quarter?

On Invalid Date, Cullinan Therapeutics (NASDAQ: CGEM) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cullinan Therapeutics's revenue was $0.00.

What was CGEM's revenue growth in the past year?

As of Q2 2024, Cullinan Therapeutics's revenue has grown null year over year. Cullinan Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.